JPRN-UMIN000005808招募中2 期
Fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in non-resectable pancreatic cancer patients. - (FOLFIRINOX): a phase II
Yokohama City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年6月20日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 76years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Age of 76 years or older. 2.Endocrine or acinar pancreatic carcinoma. 3.Brain metastases. 4.Another major cancer. 5.Active infection. 6.Chronic diarrhea. 7.Cardiac disease 8.Pregnancy or breast-feeding 9.In the UGT1A1 allele, UGT1A1 (*)28/(*)28 genotype UGT1A1 (*)28/(*)6 genotype UGT1A1 (*)6/(*)6 genotype
研究者
相似试验
进行中（未招募）
1 期
5-Fluorouracil (5-FU), folinic acid and irinotecan (FOLFIRI) versus 5-FU and folinic acid as second-line chemotherapy in patients with biliary tract cancer (IRIBIL): a randomized open-label phase 2 studybiliary tract cancer not amedable for curative resection with progressive disease after first-line chematherapy with gemcitabine and cisplatinEUCTR2015-004028-69-DEGoethe-Universität Frankfurt, PD Fabian Finkelmeier56
招募中
2 期
5-Fluorouracil (5-FU), folinic acid and irinotecan (FOLFIRI) versus 5-FU and folinic acid as second-line chemotherapy in patients with biliary tract cancer (IRIBIL): a randomized open-label phase 2 studyC22C23Malignant neoplasm of liver and intrahepatic bile ductsMalignant neoplasm of gallbladderDRKS00012595Dekanat des Fachbereichs MedizinUniversitätsklinikum der Goethe-Universität Frankfurt27
进行中（未招募）
1 期
Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer: A randomised trial assessing whether preoperative chemotherapy and/or an anti-EGFR monoclonal antibody improve outcome in high-risk operable colon cancer - FOxTROTPatients with high-risk, operable colon cancerMedDRA version: 14.1Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009956Term: Colon cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-001987-55-SEniversity Of Birmingham20
进行中（未招募）
1 期
Fluoropyrimidine, Oxaliplatin & Targeted Receptor pre-Operative Therapy for colon cancer: A randomised trial assessing whether preoperative chemotherapy and/or an anti-EGFR monoclonal antibody improve outcome in high-risk operable colon cancer - FOxTROTPatients with high-risk, operable colon cancerMedDRA version: 14.1Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10009956Term: Colon cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-001987-55-DKniversity Of Birmingham150
进行中（未招募）
1 期
A trial looking at chemotherapy and panitumumab before and after surgery for bowel cancer (FOxTROT)Patients with high-risk, operable colon cancerMedDRA version: 19.0Level: PTClassification code 10009955Term: Colon cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 19.0Level: PTClassification code 10009956Term: Colon cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2007-001987-55-GBniversity Of Birmingham1,050